Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cetogenix has developed and is scaling the Ceto-Boost™ hydrothermal oxidation platform to convert organic waste into renewable natural gas, chemicals, and biomaterials. The process maximizes resource recovery from various waste streams while eliminating contaminants. Initial trials have demonstrated successful optimization for agricultural wastes such as dairy manure. The next phase involves constructing a demonstration plant at a New Zealand farm site to validate methane gas and fertilizer production at scale
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cetogenix.